Adjuvant therapy of resected non-small-cell lung cancer.
The administration of adjuvant therapy after complete resection of non-small-cell lung cancer is controversial. Radiation therapy and chemotherapy have been used individually and concomitantly in efforts to prevent local recurrence and improve survival. However, recent phase II and III trials and a meta-analysis have produced conflicting results. Postoperative adjuvant therapy remains a subject of active investigation.
Keller
S M
SM
Department of Surgery, Beth Israel Medical Center, New York, New York 10804, USA. skeller@bethisraelny.org
D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy* / Q000601:surgery; D010347:Patient Care Planning; D011379:Prognosis; D018714:Radiotherapy, Adjuvant